Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone

[1]  H. Katus,et al.  Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  J. Hancox,et al.  Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652 , 2003, British journal of pharmacology.

[3]  J. Mitcheson.  Drug binding to HERG channels: evidence for a ‘non‐aromatic’ binding site for fluvoxamine , 2003, British journal of pharmacology.

[4]  W. Alvarez,et al.  Safety of Antidepressant Drugs in the Patient with Cardiac Disease: A Review of the Literature , 2003, Pharmacotherapy.

[5]  Michael C Sanguinetti,et al.  Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain. , 2003, Molecular pharmacology.

[6]  A. Camm,et al.  Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.

[7]  D. Nutt,et al.  Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death , 2003, Journal of clinical psychopharmacology.

[8]  M. Sanguinetti,et al.  Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Jules C Hancox,et al.  Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes. , 2002, Journal of pharmacological and toxicological methods.

[10]  Dierk Thomas,et al.  Bertosamil blocks HERG potassium channels in their open and inactivated states , 2002, British journal of pharmacology.

[11]  D. Vitezić,et al.  Erectile dysfunction: oral pharmacotherapy options. , 2002, International journal of clinical pharmacology and therapeutics.

[12]  Michael C Sanguinetti,et al.  Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block* , 2002, The Journal of Biological Chemistry.

[13]  P. Goodnick,et al.  Psychotropic drugs and the ECG: focus on the QTc interval , 2002, Expert opinion on pharmacotherapy.

[14]  Jules C Hancox,et al.  Inhibitory actions of the selective serotonin re‐uptake inhibitor citalopram on HERG and ventricular L‐type calcium currents , 2002, FEBS letters.

[15]  Dierk Thomas,et al.  The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. , 2002, The Journal of pharmacology and experimental therapeutics.

[16]  A. de Meester,et al.  FATAL OVERDOSE WITH TRAZODONE : CASE REPORT AND LITERATURE REVIEW , 2001, Acta clinica Belgica.

[17]  A. Brown,et al.  High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872. , 2001, The Journal of pharmacology and experimental therapeutics.

[18]  Jun Chen,et al.  A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Ho,et al.  Blockade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline , 2000, British journal of pharmacology.

[20]  John S. Mitcheson,et al.  Trapping of a Methanesulfonanilide by Closure of the Herg Potassium Channel Activation Gate , 2000, The Journal of general physiology.

[21]  J. Hancox,et al.  Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline , 1999, British journal of pharmacology.

[22]  A. Brown,et al.  Pathways of HERG inactivation. , 1999, American journal of physiology. Heart and circulatory physiology.

[23]  J. Levenson.  Prolonged QT interval after trazodone overdose. , 1999, The American journal of psychiatry.

[24]  M. Keating,et al.  MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.

[25]  W. Kübler,et al.  Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[26]  J. Sánchez-Chapula,et al.  Mechanism of block of cardiac transient outward K+ current (I(to)) by antidepressant drugs. , 1998, Journal of cardiovascular pharmacology.

[27]  Devane Cl.  Differential pharmacology of newer antidepressants. , 1998 .

[28]  E. Speckmann,et al.  Follicular Tissues Reduce Drug Effects on Ion Channels in Oocytes of Xenopus laevis , 1997, The European journal of neuroscience.

[29]  M. Sanguinetti,et al.  Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. , 1996, Circulation research.

[30]  Gary Yellen,et al.  The inward rectification mechanism of the HERG cardiac potassium channel , 1996, Nature.

[31]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[32]  J. Chant,et al.  GTPase cascades choreographing cellular behavior: Movement, morphogenesis, and more , 1995, Cell.

[33]  D. McTavish,et al.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. , 1994, Drugs & aging.

[34]  Mark E. Anderson,et al.  Cardiac ion channels. , 2002, Annual review of physiology.

[35]  J. Feighner.  Mechanism of action of antidepressant medications. , 1999, The Journal of clinical psychiatry.